证券日报网讯兄弟科技8月19日在互动平台回答投资者提问时表示，公司目前拥有香兰素及乙基香兰素 合计1万吨产能，公司将加大国内以及其他海外市场的开拓和推广力度，积极开拓新产品品类，加快产 品创新，提升产品竞争力，尽可能减少反倾销对公司造成的不利影响。 （文章来源：证券日报） ...

Group 1: Company Overview and Product Information - The company has four production bases, with key products including Vitamin K3, chromium tanning agents, and various pharmaceutical raw materials [1] - The main applications of para-hydroxyphenol span multiple industries, including food, daily chemicals, pesticides, pharmaceuticals, dyes, and polymer materials [1] - The company has officially started selling para-hydroxyphenol in the PEEK field and is currently in the verification stage with major domestic PEEK manufacturers [2] Group 2: Regulatory Approvals and Product Registration - The company has obtained various regulatory approvals for iodine contrast agents, including registrations in China, India, Japan, and CEP certification [2] - Currently, the company holds registration certificates for two formulation products, with one product, Bisoprolol fumarate tablets, having commenced market promotion in 2024 [2] Group 3: Financial Performance and Inventory Management - The growth in performance for the first half of 2025 is attributed to the year-on-year price increase of certain vitamin products and a decrease in production costs [2] - The company maintains a large ending inventory balance due to its diverse product lines, which include vitamins, flavors, raw materials, and chromium salts, and is focused on improving asset turnover efficiency [2] Group 4: Supply Chain and Procurement - The company sources chromium ore locally in South Africa as needed and currently has no plans to acquire chromium mines [2] Group 5: Disclosure and Compliance - The investor relations activity did not involve any undisclosed significant information [2]